$0.73 -0.04 (-5.18%)

AETHLON MEDICAL INC (AEMD)

Aethlon Medical Inc. (AEMD) is a biotechnology company focused on developing therapeutic and diagnostic technologies for infectious disease and cancer. The company is known for its Hemopurifier, a device designed to capture and remove viruses, tumor-derived antigens, and other pathogenic substances from the blood. Aethlon aims to address unmet medical needs through its innovative biofiltration and immunotherapy-based platforms.

🚫 AETHLON MEDICAL INC does not pay dividends

Company News

Aethlon Medical Announces Pricing of $4.5 Million Public Offering
Benzinga • Prnewswire • September 4, 2025

Aethlon Medical has priced a public offering of 5 million shares and warrants at $0.90 per share, expecting to raise approximately $4.5 million for general corporate purposes including clinical trials and research.

Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream
GlobeNewswire Inc. • Emerginggrowth.Com • June 17, 2025

EmergingGrowth.com announces the schedule for the 83rd Emerging Growth Conference on June 17-18, 2025, featuring presentations from various companies in growth sectors.

Strategies for Trading Options With Penny Stocks
PennyStocks • J. Phillip • June 7, 2024

Trading options with penny stocks? Here's what you need to kno The post Strategies for Trading Options With Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Wall Street Breakfast: What Moved Markets
Seeking Alpha • Wall Street Breakfast • June 12, 2021

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.